| Product Information |
|
| Registration Number |
DR-XY48228
|
| Generic Name |
Ciprofloxacin (As Lactate)
|
| Brand Name |
Ciprobay
|
| Dosage Strength |
2 mg/mL
|
| Dosage Form |
Solution for Intravenous (IV) Infusion
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Antibacterial (Fluroquinolone)
|
| Packaging |
250 mL-capacity Type II colorless siliconized glass vial
with gray chlorobutyl stopper and aluminum-shell polypropylene plastic button flanged closure
(Box of 1 vial x 200 mL-net content)
100 mL-capacity Type II colorless siliconized glass vial with gray chlorobutyl stopper and aluminum-shell polypropylene plastic button flanged closure
(Box of 1 vial x 100 mL-net content)
|
| Manufacturer |
Fresenius Kabi Italia S.R.L.
|
| Country of Origin |
Italy
|
| Trader |
N/A
|
| Importer |
Bayer Philippines, Inc.
|
| Distributor |
Bayer Philippines, Inc.
|
| Application Type |
Initial (Correction)
|
| Issuance Date |
30 July 2024
|
| Expiry Date |
26 July 2027
|